Replies to post #88306 on Innovation Pharmaceuticals Inc (IPIX)

[Ultimate01]

I gave it quite a bit of thought and think that maybe she felt she would do better with a drug that is further along the developmental pathway that has also shown to be very promising for ovarian cancer such as Pfizer’s Pfizer’s Palbociclib (PD-0332991). This is all just pure speculation on my part but just think, stage IV cancer is a desperate stage to be in and being able to choose a phase III drug that has some sort of public track record over a Phase I drug that no one even knows exists is very alluring.

GO Kevetrin and I hope whatever she decided works for her!!!

[JUST 10-11-12]

could be 10-20 reasons! no one except the client and her
immediate family friends will know....but the result of the compound are unquestionable.

[brucethepotter]

I believe I read that one of the tests for a marker had a higher number and she left because of that. And then it was said that this is a case of treating by a number and not the patient results. This is an incomplete explanation from memory so someone please fix the details. I think it was a Karen post.